- Home
- DSGX vs LEGN Comparison
DSGX vs LEGN Comparison
Compare DSGX & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGX
- LEGN
- Stock Information
- Founded
- DSGX 1981
- LEGN 2014
- Country
- DSGX Canada
- LEGN United States
- Employees
- DSGX N/A
- LEGN N/A
- Industry
- DSGX Computer Software: Prepackaged Software
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- DSGX Technology
- LEGN Health Care
- Exchange
- DSGX Nasdaq
- LEGN Nasdaq
- Market Cap
- DSGX N/A
- LEGN 9.1B
- IPO Year
- DSGX 1999
- LEGN 2020
- Fundamental
- Price
- DSGX $106.53
- LEGN $45.57
- Analyst Decision
- DSGX Buy
- LEGN Strong Buy
- Analyst Count
- DSGX 11
- LEGN 13
- Target Price
- DSGX $106.00
- LEGN $81.46
- AVG Volume (30 Days)
- DSGX 116.3K
- LEGN 1.3M
- Earning Date
- DSGX 12-03-2024
- LEGN 11-12-2024
- Dividend Yield
- DSGX N/A
- LEGN N/A
- EPS Growth
- DSGX 13.00
- LEGN N/A
- EPS
- DSGX 1.48
- LEGN N/A
- Revenue
- DSGX $607,697,000.00
- LEGN $455,991,000.00
- Revenue This Year
- DSGX $13.91
- LEGN $108.95
- Revenue Next Year
- DSGX $10.76
- LEGN $81.26
- P/E Ratio
- DSGX $72.41
- LEGN N/A
- Revenue Growth
- DSGX 15.40
- LEGN 176.93
- 52 Week Low
- DSGX $70.92
- LEGN $38.60
- 52 Week High
- DSGX $108.02
- LEGN $70.13
- Technical
- Relative Strength Index (RSI)
- DSGX 57.33
- LEGN 44.41
- Support Level
- DSGX $103.61
- LEGN $44.56
- Resistance Level
- DSGX $107.38
- LEGN $46.15
- Average True Range (ATR)
- DSGX 1.76
- LEGN 2.05
- MACD
- DSGX -0.09
- LEGN 0.19
- Stochastic Oscillator
- DSGX 65.53
- LEGN 33.83
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.